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Background & aims: Modiﬁcation of the amount and type of dietary fat has diverse effects on cardio-
vascular risk.
Methods: We recruited 54 abdominally obese subjects to participate in a prospective cross-over design,
single-blind trial comparing isocaloric 2000 kcalMUFAor carbohydrate-enricheddietwith SFA-enricheddiet
(control). The control diet consisted of 15E% protein, 53E% carbohydrate and 32E% fat (12E% SFA,13E%MUFA).
A total of ~7E%ofMUFAor reﬁned carbohydratewas exchangedwith SFA in theMUFA-rich and carbohydrate-
rich diets respectively for 6-weeks. Blood sampleswere collected at fasting upon trial commencement and at
week-5 and 6 of each dietary-intervention phase to measure levels of cytokines (IL-6, IL-1b), C-reactive
protein (CRP), thrombogenic markers (E-selectin, PAI-1, D-dimer) and lipid subfractions. Radial pulse wave
analysis anda 6-hpostprandialmixedmeal challengewere carriedout atweek-6of eachdietary intervention.
Blood samples were collected at fasting, 15 and 30 min and hourly intervals thereafter till 6 h after a mixed
meal challenge (mufﬁn and milkshake) with SFA or MUFA (872.5 kcal, 50 g fat, 88 g carbohydrates) or CARB
(881.3 kcal, 20 g fat, 158 g carbohydrates)- enrichment corresponding to the background diets.
Results: No signiﬁcant differences in fasting inﬂammatory and thrombogenic factors were noted be-
tween diets (P > 0.05). CARB meal was found to increase plasma IL-6 whereas MUFA meal elevated
plasma D-dimer postprandially compared with SAFA meal (P < 0.05). Comparing the 3 meals, there were
similar postprandial elevations in IL-6 and D-dimer and postprandial reductions in PAI-1, augmentation
index and pressure (time effect: P < 0.05). CARB diet was found to reduce HDL3 by 7.8% and increase
small dense HDL (sdHDL) by 8.6% compared with SFA diet (P < 0.05). SFA diet increased large HDL
subfractions compared with both CARB and MUFA diets by 4.9% and 6.6% (P < 0.05), respectively.
Conclusions: Overall, the evidence presented in this study suggests that the replacement of SFA with
MUFA or reﬁned carbohydrates may not improve inﬂammatory and thrombogenic markers in abdomi-
nally overweight individuals. Indeed increased reﬁned carbohydrates consumption adversely impacts
fasting HDL subfractions.
This trial was registered under ClinicalTrials.gov. Identiﬁer no. NCT01665482.
© 2016 The Authors. Published by Elsevier Ltd. This is an open access article under the CC BY-NC-ND
license (http://creativecommons.org/licenses/by-nc-nd/4.0/).1. Introduction
Obesity is a major health concern, central obesity is of more
clinical relevance and related to a cluster of metabolic disorders.mail.com (K.-T. Teng).
Ltd. This is an open access article u
al., Effects of exchanging carb
th abdominal obesity: A ranCentral obesity predisposes to a higher risk of developing cardio-
vascular diseases, which is related to early onset of pro-
inﬂammatory and pro-thrombogenic states. Studies have reported
higher levels of interleukin-6 (IL-6) and plasminogen inhibitor
activator-1 (PAI-1) in abdominally obese individuals [1e3]. The
accumulation of adipocytes in the abdominal region triggers the
release of an array of fat soluble cytokines [4]. The consumption of
high fat diets is thought to increase body weight and abdominal fatnder the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
ohydrate ormonounsaturated fat with saturated fat on inﬂammatory
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Abbreviations
IL-6 interleukin-6
PAI-I plasminogen inhibitor activator-1
SFA saturated fatty acid
CRP C-reactive protein
MUFA monounsaturated fatty acid
IL-1b Interleukin-1b
MPOB Malaysian Palm Oil Board
sdHDL small dense HDL
iAUC incremental area under the curve
K.-T. Teng et al. / Clinical Nutrition xxx (2016) 1e92deposition, with saturated fatty acid (SFA) considered the chief
culprit [5]. In vivo animal data suggest that SFA in particular pal-
mitic acid increase cytokines e.g. IL-6 and interleukin-1. SFA and
trans fatty acids have been reported to increase C-reactive protein
(CRP) [6] but limited data is available to support this. The recom-
mendation to reduce the intake of SFA by replacing with mono-
unsaturated fatty acid (MUFA) or complex carbohydrates has been
proposed by the World Health Organisation [7] and other regula-
tory parties [8,9] based on the impact of SFA on the lipid proﬁle.
Data on other clinically relevant metabolic risk biomarkers how-
ever is scarce, in particular in populations at high risk of developing
cardiovascular disease. The replacement of SFA with carbohydrates
has received much debate as increased reﬁned carbohydrates
rather than complex carbohydrates intake has been reported to be
linked with impaired insulin sensitivity and inﬂammatory states
[10e13].
In order to prevent the possible exposure to cardiovascular
disease risk in centrally overweight individuals, who comprise 50%
of the population in bothWestern and Asian countries, determining
the best dietary macronutrient composition with least negative
metabolic and vascular impact is critical. Therefore, we set out to
investigate the effect of replacement of SFA with MUFA or reﬁned
carbohydrates on subclinical inﬂammation, the thrombogenic
state, as well as lipid subfractions in centrally overweight subjects
who are at risk of developing cardiovascular disease.2. Materials and methods
2.1. Subjects
The study was approved by the Medical Ethics Committee of
University Malaya Medical Centre, Kuala Lumpur, Malaysia (refer-
ence no.: 871.5) and registered at ClinicalTrial.gov (Identiﬁer:
NCT01665482). Of 54 abdominally overweight subjects recruited,
47 completed the study. Abdominally obese males and females
(waist circumference >90 cm for male, >80 cm for female), age
20e60 y were included. Subjects with a medical history of car-
diovascular disease, diabetes, dyslipidemia; current use of antihy-
pertensive or lipid lowering medication; plasma cholesterol
>6.5 mmol/L, triacylglycerol [14] >4.5 mmol/L; alcohol intake
exceeding a moderate intake (>28 units per week); pregnancy,
smoker and breastfeeding were excluded.Fig. 1. Study design.2.2. Study design
This was a prospective cross-over design, single-blind trial
comparing isocaloric 2000 kcal/day MUFA or CARB-enriched diet
with SFA-enriched diet (control). The control SFA-enriched diet
consisted of 15E% protein, 53E% CARB and 32E% fat (12E% SFA, 13E%Please cite this article in press as: Teng K-T, et al., Effects of exchanging carb
and thrombogenic responses in subjects with abdominal obesity: A ran
10.1016/j.clnu.2016.08.026MUFA). A total of ~7E% of MUFA or CARBwas exchanged with SFA in
the MUFA-rich and CARB-rich diets respectively for 6-weeks. Sub-
jects were blinded and randomly allocated to 3 consecutive 6-week
dietary treatments using an orthogonal allocation process (ABC,
BCA, CAB) using Excel software. At any timepoint, each treatment
was allocated 18 subjects with equal gender distribution. Blood
samples were collected at baseline (prior to the commencement of
study intervention), week 5 and 6. A postprandial mixed meal
challenge was conducted at week 6 of each dietary treatment
where hourly blood samples collection was done after test meal
consumption. Radial pulse wave analysis was measured at baseline
and week-6 of each intervention (before meal and 4 h after meal
during mixed meal challenge). Fasting plasma IL-6 was the primary
outcome of the present study. Secondary outcomes were inter-
leukin-1b (IL-1b), CRP, E-selectin, PAI-1, D-dimer, lipid subfractions
and radial pulse wave analyses. The study design is reported in
Fig. 1.2.3. Recruitment methodology
The study intervention was carried out between March and July
2012 at the research institute of Malaysian Palm Oil Board (MPOB).
Subjects were recruited via advertisement using posters, internal
mail circulation and phone call. Subjects were briefed and provided
with a study information brochure. The interested subjects were
initially interviewed via a questionnaire over the telephone. Those
who met the initial inclusion criteria were invited for a health
screening session including medical examination and biochemical
proﬁle (glucose, full blood count, lipid proﬁle, kidney and liver
function tests). The subjects signed informed consent and provided
a 3-day dietary record for the assessment of habitual calorie intake.2.4. Experimental diets
Habitual dietary intake requirement prior to enrolment was
estimated from a 3-day weighed food record using Nutritionist-
Pro™ (AXXYA Systems LLC., Stafford, TX, USA). As summarized in
Table 1, the experimental diets provided 2000 kcal/day with 55E%
carbohydrates, and 32E% fat for both MUFA and SFA diets; a 7E%
exchange with fat (in the form of SFA) was applied for CARB diet
resulting in a higher carbohydrate and lower fat content compared
with the other 2 diets (62E% carbohydrates, 25E% fat). Protein
content was standardized across diets at 15E%. Test fats were palm
olein IV56 (purchased fromMOI FoodMalaysia Sdn. Bhd., Malaysia)
blended with sunﬂower oil (purchased from Sunlico®, Yee Lee
Edible Oils, Malaysia) for SFA diet, high oleic sunﬂower oil (pur-
chased from Neuvida®, Yee Lee Edible Oils, Malaysia) blended with
sunﬂower oil for MUFA and CARB diets. 45 g test fat was incorpo-
rated into cooking for both SFA and MUFA diets; whereas 34 g fat
was incorporated into CARB diet. The sugar sources for CARB dietohydrate ormonounsaturated fat with saturated fat on inﬂammatory
domized controlled trial, Clinical Nutrition (2016), http://dx.doi.org/
Table 1
Macronutrient composition of experimental diets and postprandial mixed meals.
SFA CARB MUFA
Experimental diets
Total calorie (kcal/day) 2054.9 ± 205.7 2081.2 ± 198.1 2054.9 ± 205.7
Total calorie (MJ/day) 8.6 ± 0.9 8.7 ± 0.8 8.6 ± 0.9
Protein (E%) 13.8 ± 2.2 14.3 ± 2.3 13.8 ± 2.2
Carbohydrate (E%) 54.7 ± 4.7 61.4 ± 3.8 54.7 ± 4.7
Dietary sugar (g)a 63.2 ± 15.3 91.3 ± 25.7 63.2 ± 15.3
Fat (E%) 31.5 ± 4.3 24.3 ± 2.7 31.5 ± 4.3
SFA (E%) 12.0 ± 0.4 4.5 ± 0.5 5.0 ± 0.8
MUFA (E%) 13.1 ± 0.3 14.0 ± 0.5 20.5 ± 1.0
PUFA (E%) 6.4 ± 0.6 5.8 ± 0.5 6.0 ± 0.5
Dietary ﬁber (g)a 11.3 ± 3.7 12.8 ± 3.7 11.3 ± 3.7
Snacks (cupcake and pancake)
Total calorie (kcal/day) 128.2 ± 127.8 139.2 ± 131.9 133.2 ± 137.0
Total calorie (MJ/day) 0.5 ± 0.5 0.6 ± 0.6 0.6 ± 0.6
Mixed mealsa
Total calorie (kcal) 872.1 881.3 872.1
Total calorie (MJ) 3.7 3.7 3.7
Protein (g) 15.8 15.8 15.8
Carbohydrate (g) 88.0 157.6 88.0
Dietary sugar (g) 56.3 123.2 56.3
Fat (g) 50.7 20.8 50.7
SFA (g) 19.7 1.5 3.7
MUFA (g) 20.6 13.5 36.9
PUFA (g) 9.7 5.0 9.1
Dietary ﬁber (g) 0.7 0.7 0.7
Mean values ± SD. Duplicates of the meals were collected for total fat (Soxhlet
method) and protein content (Kjeldah method).
Abbreviations: E, energy; SFA, saturated fatty acid; CARB, carbohydrate; MUFA,
monounsaturated fatty acid; PUFA, polyunsaturated fatty acid.
a Calculated using Nutritionist Pro™ software (AXXYA Systems LLC. Texas, USA).
K.-T. Teng et al. / Clinical Nutrition xxx (2016) 1e9 3were rose syrup, honey and barley drinks which provided 40, 40,
60 g sucrose respectively (mean glycemic index 35.5, glycemic load
21.6). All other food components were identical between diets:
breakfast consisting of a serving of reﬁned carbohydrate (fried rice
or fried noodles) plus 1 carbohydrate snack, a serving of fruit and a
serving of drink; lunch and dinner: a serving of protein source (ﬁsh,
meat or chicken), 1 serving of carbohydrate-rich foods (rice, noo-
dles, or spaghetti), 1 serving of vegetables and fruits for each meal.
Cholesterol intake was limited to <200 mg/day by restricting egg
and seafood intake, and only providing lean meat without skin.
Subjects were provided three 5-day cyclemenuswith breakfast and
lunch served at the dining hall of research institute, and dinner was
packed home.
Additional energy requirement was adjusted using snacks coded
to blind the subjects (cupcake with 3 ﬂavors-vanilla, orange and
strawberry, and pancakes) containing ~156 kcal with matching
nutrient proportion with the background diet. Amount of test fats
needed was calculated for everyday cooking and provided to the
caterer. Subjects were provided guidelines to prepare meals at
home using test cooking oils during weekends and holidays.2.5. Mixed meal composition
The mixed meal consisted of a high fat (50 g fat) mufﬁn and a
strawberry-ﬂavored milkshake (Nesquik® (Nestle, Switzerland)) in
the case of subjects on a background SFA/MUFA diet-intervention;
additional carbohydrate content in a low fat/high carbohydrate
mufﬁn (20 g fat) and a milkshake was supplied by 70 g Valens
Caborie® glucose polymers module (Pharm-D, USA) for subjects on
a CARB background diet. The high fat challenge meals (for both SFA
and MUFA meals) provided 900.8 kcal (3.78 MJ), 90.4 g carbohy-
drates and 50 g test fats; whereas the low fat/high carbohydrate
challenge meal (CARB meal) provided 803.2 kcal (3.73 MJ), 221.3 g
carbohydrates and 20 g test fat. The CARB meal utilized 61.6 gPlease cite this article in press as: Teng K-T, et al., Effects of exchanging carb
and thrombogenic responses in subjects with abdominal obesity: A ran
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pared in batches before the study day and stored in 20 C freezer.
The mufﬁns were heated in the microwave before serving to sub-
jects during study day.
2.6. Mixed meal challenge procedure
On the last day of each 6-week intervention, subjects were
provided a low fat chicken-ﬂavored instant cup porridge meal
(providing 180 kcal with 1 g fat) for dinner and required to fast after
22:00. The subjects were asked to refrain from strenuous exercise,
caffeine and alcohol intake a day before the mixed meal challenge
day. On arrival at the center on the morning of the study, subjects
ﬁlled up a questionnaire to assess activity and food intake a day
before. The subject's blood pressure and radial pulse wave analyses
were measured using SphygmoCor System (AtCor Medical,
Australia). A venous cannula was inserted into the antecubital vein
of the forearm to facilitate multiple blood samples. The subject was
then served with challenge test meal to consume within 10 min.
Subsequent blood samples were collected at 15 min, 30 min, and
hourly intervals till 6 h. At 4-h, subject's blood pressure and radial
pulse wave analyses were measured again by the same technician.
At the end of 6 h, subjects were provided lunch to consume.
2.7. Compliance measures
The attendance and meal intake were closely monitored by a
nutritionist. Subjects found skipping meals were monitored closely
and those found to miss over 10% of the meals over the course of
each 6-week intervention period were considered drop-outs. No
subjects were requested to quit the study due to noncompliance
based on these criteria. Body weight was monitored bi-weekly and
subjectswith bodyweightﬂuctuationsmore than 2 kgwere advised
to adjust calorie intake. Total plasma fatty acid and erythrocyte
membrane phospholipid fatty acid composition were analyzed at
week 6 of each diet-treatment to monitor subject compliance.
2.8. Fasting blood sample collection
Fasting blood samples were collected at baseline, week 5 and 6
of each dietary treatment. Serum samples for the analyses of tri-
aclyglycerol, CRP and lipid proﬁle were collected into tubes sili-
conized with clot activator. EDTA K3 tubes (1.2e2.0 mg EDTA/1 mL
of blood) were used for plasma cytokines and citrated tubes (3.2%
or 0.109 mol/l sodium citrate) for thrombogenic markers. All sam-
ples were centrifuged at 1529  g for 15 min and stored at 80 C
until analysis. Packed erythrocytes (after plasma removal) were
stored at 4 C and analyzed within 5 days.
2.9. Laboratory analyses
IL-6, IL-1b, and E-selectin were analyzed using Quantikine HS®
colorimetric sandwich ELISA (R&D System, USA). The interassay
values were 6.4, 10.8, 5.8% respectively, n ¼ 22. PAI-1 was analyzed
using IMUBIND® plasma PAI-1 ELISA kit (Sekisui Diagnostics, USA)
with interassay values at 7.2%, n ¼ 22. Plasma D-dimer was assayed
by IMUCLONE™ D-dimer ELISA kit (Sekisui Diagnostics, USA)
(interassay CV% ¼ 3.3%, n ¼ 22). Lipid proﬁle and CRP assay were
analyzed by an accredited clinical laboratory (Pathlab & Clinical
Laboratory Sdn. Bhd., Malaysia) using ADVIA 2400 Chemistry
(Siemens Healthcare Diagnostics Inc., USA). The interassay CV% for
total cholesterol, triacylglycerol, apo A-1, apo B-100 and CRP assays
were 1.5% (n ¼ 2), 2.6% (n ¼ 2), 1.1% (n ¼ 2), 0% (n ¼ 2), 1.7% (n ¼ 2)
respectively (Siemen Healthcare Diagnostics Products Inc., USA).
LDL cholesterol was calculated using Friedewald's equation. Radialohydrate ormonounsaturated fat with saturated fat on inﬂammatory
domized controlled trial, Clinical Nutrition (2016), http://dx.doi.org/
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Medical, Australia) by the same technician with intraassay CV at
3.8% (n ¼ 47).
2.10. Statistics
A sample size of 48 subjects was calculated to have 80% power to
detect a difference of 0.5 SD unit change of IL-6 at P ¼ 0.01. SPSS
version 18 (SPSS Inc, Chicago, IL) and GraphPad Prism software
version 5.02 (Graph Pad software, Inc., La Jolla, CA, USA) were used
for statistical analyses. Data distribution normality was determined
and logarithmic transformation conducted for data not normally
distributed. Fasting concentrations were tested at week 5 and 6 for
any time trends. No time trend was detected and data were aver-
aged and presented as mean/geometric mean ± SEM for fasting
measurements or mean/geometric mean (95% CI) for postprandial
measurements. Fasting data were analyzed by repeated measure
ANOVA; whereas postprandial data were analyzed by one way
repeated measure ANOVA, with time and meal as within subject
factors and gender as between subject variables. Bonferroni post-
hoc test was conducted for comparison between treatments. In-
cremental area under the curve (iAUC) was calculated for all
postprandial data.
3. Results
The characteristics of 47 subjects (35 women, 12 men) who
completed the 3 x 6-week dietary intervention are presented inTable 2
Characteristics of study subjects.
Allb
Physical characteristics
Age (y) 32.8 ± 8.7
Gender
Female (n) 35
Male (n) 12
Height (m) 159.4 ± 7.8
Weight (kg) 74.2 ± 14.6
BMI (kg/m2) 28.7 ± 4.1
Waist (cm) 94.8 ± 10.2
Body fat (%) 36.6 ± 7.9
Systolic BP (mmHg) 124.5 ± 12.4
Diastolic BP (mmHg) 81.8 ± 10.7
Aortic augmentation pressure (mmHg) 6.1 ± 4.9
Aortic augmentation index (%) 18.7 ± 12.8
Biochemical proﬁle
Serum total cholesterol (mmol/L) 5.0 ± 0.8
Serum HDL cholesterol (mmol/L) 1.3 ± 0.3
Serum LDL cholesterol (mmol/L) 3.1 ± 0.7
Serum triacylglycerol (mmol/L) 1.2 ± 0.7
Total: HDL cholesterol 4.0 ± 0.8
Plasma glucose (mmol/L) 5.8 ± 0.8
Plasma IL-6 (pg/ml)a 1.4 ± 0.8
Plasma IL-1b (pg/ml) 0.2 ± 0.1
Serum CRP (mg/L)a 3.7 ± 4.3
Plasma E-selectin (ng/mL)a 36.3 ± 13.5
Plasma PAI-1 (ng/ml) 63.2 ± 31.3
Plasma D-dimer (ng/ml)a 254.0 ± 137.6
Dietary intakec
Energy (kcal/day) 2051.8 ± 545.3
Protein (E%) 16.3 ± 2.8
Carbohydrate (E%) 57.3 ± 7.2
Fat (E%) 26.9 ± 6.2
Abbreviations: BP, blood pressure; IL-6, interleukin-6; IL-1b, interleukin-1b; CRP, C-
reactive protein; PAI-1, plasminogen activator inhibitor-1.
a Means or geometric means ± SD.
b Ethnicity: Malay n ¼ 47.
c Determined from 3-day weighed diet record using Nutritionist Pro™ software
(AXXYA Systems LLC. Texas, USA).
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into three groups: 5 subjects dropped out during the ﬁrst inter-
vention (2 were unable to commit, 1 had health problems, 2
became pregnant) and 2 dropped out during second intervention
(1- health problems, 1- pregnant). 47 subjects completed fasting
blood collection and all 3 dietary interventions, 1 subject refused to
participate in the postprandial mixed meal challenge and 46 sub-
jects (34 women, 12 men) completed all 3 postprandial mixed meal
challenges.
3.1. Compliance
Extra energy intake from daily snacks was not signiﬁcantly
different between diet groups (Table 1). Full meal intake was ach-
ieved in 97.1 ± 4.4%, 98.0 ± 3.2% and 97.1 ± 5.1% of subjects for SFA,
CARB and MUFA diets respectively. The meal appreciation and
palatability assessed by VAS (ranging from 0 to 10) were 7.0 ± 1.2,
7.1 ± 1.3, 6.9 ± 1.4 and 7.2 ± 1.3, 7.3 ± 1.3, 7.1 ± 1.4 for SFA, CARB and
MUFA diets respectively. Body weight was constant across in-
terventions at weight 73.8 ± 14.4 kg, 73.9 ± 14.6 kg and
73.9 ± 14.3 kg, respectively for SFA, CARB and MUFA diets. Total
plasma fatty acid and erythrocyte membrane phospholipid fatty
acid composition reﬂected dietary intake indicating good compli-
ance. Palmitic acid content was higher (P < 0.05) after SFA diet
(26.8 ± 2.3%) compared with CARB (26.3 ± 1.8%) and MUFA diets
(26.0 ± 2.0%). Overall subject compliance was good.
3.2. Fasting metabolic risk markers
Table 3 summarizes fasting measurements for inﬂammatory
and thrombogenic markers. The primary outcome, fasting plasma
IL-6 levels were similar after exposure to 6 weeks of SFA, CARB and
MUFA diets respectively. Neither were there signiﬁcant differences
in fasting plasma IL-1b, CRP, E-selectin, PAI-1 and D-dimer between
the 3 diets after 6 weeks of exposure.
The results of fasting lipids after each dietary intervention are
proﬁled in Table 4. As expected, MUFA diet resulted in a slightly
lower total cholesterol level and LDL cholesterol level compared
with SFA diet P < 0.05). CARB diet was associated with lower HDL
cholesterol level compared with SFA diet (P < 0.05). No difference
was observed between diets in total: HDL cholesterol ratio, VLDL
cholesterol, apo A-1, apo B-100, lp(a) and TAG levels. Interestingly,
CARB diet resulted in lower HDL3 subfraction and higher small
dense HDL (sdHDL) subfraction compared with SFA diet (P < 0.05).
SFA diet increased large HDL subfractions compared with both
CARB and MUFA diets (P < 0.05), respectively.
3.3. Postprandial metabolic responses
The postprandial response of plasma cytokines and thrombo-
genic markers over 6 h to the mixed meal challenge with macro-
nutrient composition echoing the 3 background diets are shown in
Fig. 2, graphs A-F. With all 3 background diets, IL-6 rose after the
postprandial challenge. Repeated measure ANOVA did not show
signiﬁcant differences between diets in plasma IL-6 at individual
time-points over 6 h (time effect: P ¼ 0.000, meal  time interac-
tion: P¼ 0.245). However iAUC0e6 h IL-6 was 66% higher after CARB
challenge compared with SFA challenge (P < 0.05). Time (P¼ 0.020)
but not meal  time interaction (P ¼ 0.077) was observed for
plasma IL-1b over 6 h. Plasma IL-1bwas found to fall below baseline
at 2 h with all 3 meals. Repeated measure ANOVA for E-selectin
showed signiﬁcant meal  time interaction (P ¼ 0.035) and a
borderline signiﬁcant value for iAUC between the 3 challengemeals
(P ¼ 0.051). There was a time trend effect (P ¼ 0.000) where PAI-1
levels were reduced 4 h after all 3 challenge meals but noohydrate ormonounsaturated fat with saturated fat on inﬂammatory
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Table 3
Fasting inﬂammatory and thrombogenic variables after following SFA-, CARB- and MUFA diets for 6-week.
SFA diet CARB diet MUFA diet
IL-6 (pg/mL)a 1.523 (1.305, 1.740) 1.562 (1.264,1.861) 1.523 (1.305, 1.740)
IL-1b (pg/mL) 0.262 (0.237, 0.286) 0.253 (0.228, 0.277) 0.253 (0.227, 0.279)
CRP (mg/mL)a 4.023 (2.819, 5.227) 3.845 (2.572, 5.117) 3.702 (2.624, 4.780)
E-selectin (ng/mL)a 36.47 (32.30, 40.73) 36.53 (32.40, 40.83) 36.53 (32.40, 40.65)
PAI-1 (ng/mL) 63.85 (55.88, 71.81) 62.48 (54.90, 70.07) 63.91 (56.16, 71.66)
D-dimer (ng/mL)a 245.3 (213.7, 276.8) 260.7 (221.2, 300.0) 257.1 (223.2, 291.0)
Aortic systolic pressure (mmHg) 113.4 (109.6, 117.3) 109.4 (106.4, 112.4) 109.5 (106.4, 112.6)
Aortic diastolic pressure (mmHg) 83.28 (80.17, 86.38) 79.73 (77.18,82.28) 79.38 (76.58,82.17)
Aortic pulse pressure (mmHg) 30.13 (28.24, 32.02) 29.67 (28.06, 31.29) 30.11 (28.51, 31.72)
Aortic augmentation pressure (mmHg) 6.1 (4.8, 7.5) 5.7 (4.5, 6.9) 5.6 (4.5, 6.8)
Aortic augmentation index (%) 18.69 (15.03, 22.35) 18.22 (14.97, 21.46) 17.59 (14.51, 20.67)
Abbreviations: SFA, saturated fatty acid; CARB, carbohydrate; MUFA, monounsaturated fatty acid, IL-6, interleukin-6; IL-1b, interleukin-1b; CRP, C-reactive protein; PAI-1,
plasminogen activator inhibitor-1.
a Values are means or geometric means with 95% CI. n ¼ 47 (women n ¼ 35; men n ¼ 12) for all 3 dietary interventions, measured at fasting state. Data were analyzed by
repeated measures ANOVA among 3 diets.
Table 4
Fasting lipid proﬁle after following SFA-, CARB- and MUFA diets for 6-week.
SFA diet CARB diet MUFA diet
Total cholesterol (mmol/L) 4.89 (4.68, 5.09) 4.79 (4.58, 4.4.99) 4.71 (4.48, 4.94)b
LDL cholesterol (mmol/L) 3.05 (2.89, 3.21) 3.00 (2.84, 3.17) 2.89 (2.71, 3.10)b
Mean LDL particle size (nm) 270.9 (270.0, 271.9) 270.4 (269.4, 271.3) 270.7 (269.8, 271.5)
Small dense LDL (%) 4.36 (2.87, 5.84) 5.02 (3.38, 6.65) 4.66 (3.24, 6.08)
HDL cholesterol (mmol/L) 1.23 (1.17, 1.29) 1.18 (1.13, 1.24)b 1.21 (1.14, 1.28)
HDL-2 (%) 13.62 (12.53, 14.72) 13.09 (12.08, 14.09) 13.06 (12.17,13.95)
HDL-3 (%) 9.42 (8.59, 10.24) 8.74 (7.97, 9.51)b 8.95 (8.16, 9.74)
Small HDL particle (%) 11.55 (10.22, 12.88) 12.54 (11.23, 13.85)b 12.06 (10.93, 13.19)
Intermediate HDL particle (%) 54.07 (52.55, 55.59) 54.73 (53.35, 56.12) 55.75 (54.25, 57.25)b
Large HDL particle (%) 34.17 (31.84, 36.49) 32.58 (30.41, 34.76)b 32.07 (30.05, 34.09)b
Total: HDL cholesterol 4.06 (3.84, 4.28) 4.13 (3.91, 4.36) 4.01 (3.76, 4.25)
VLDL cholesterol (mmol/L) 0.76 (0.70, 0.82) 0.76 (0.70, 0.82) 0.75 (0.69, 0.82)
Apo B-100 (g/L) 0.91 (0.86, 0.96) 0.91 (0.86, 0.96) 0.90 (0.85, 0.95)
Apo A-1 (g/L) 1.27 (1.22, 1.31) 1.25 (1.21, 1.29) 1.27 (1.22, 1.32)
Apo B-100: apo A-1 0.72 (0.68, 0.77) 0.74 (0.69, 0.79) 0.72 (0.67, 0.77)
Lipoprotein (a) (mg/dL)a 16.9 (13.6, 20.2) 17.9 (14.0, 21.7) 17.4 (14.2, 20.7)
Triacylglycerol (mmol/L)a 1.34 (1.13, 1.55) 1.32 (1.14, 1.49) 1.34 (1.13, 1.55)
Abbreviations: SFA, saturated fatty acid; CARB, carbohydrate; MUFA, monounsaturated fatty acid; apo B-100, apolipoproteinB100; apo A-1, apolipoproteinA1.
a Values are means or geometric means with 95% CI. n ¼ 47 (women n ¼ 35; men n ¼ 12) for all 3 dietary interventions, measured at fasting state. Data were analyzed by
repeated measures ANOVA among 3 diets.
b Signiﬁcantly different compared with SFA (P < 0.05).
K.-T. Teng et al. / Clinical Nutrition xxx (2016) 1e9 5meal  time interaction (P ¼ 0.348) was observed. Plasma D-dimer
was found to increase after meals (time effect, P ¼ 0.000) but
meal  time interaction was similar between meals (P ¼ 0.889).
iAUC showed that MUFA meal increased D-dimer 43% more than
SFA over 6 h compared with SFA meal (P < 0.05). iAUC did not differ
between diets for IL-1b, E-selectin, PAI-1 over 6 h (P > 0.05). There
was no signiﬁcant time (P ¼ 0.358) and meal x time effect
(P¼ 0.549) on serum CRP responses. The 6-h postprandial response
and iAUC for serum triacylglycerol are shown in Fig. 2I. There was
signiﬁcant meal  time interaction (P ¼ 0.002) based on deviations
frombaseline. Peak triacylglycerol was at 4 h after all meals, and the
iAUC triacylglycerol for CARB meal was lower than that with SFA
and MUFA meal (P < 0.000).
3.4. Pulse wave analysis
Augmentation index (%) and augmentation pressure as in-
dicators of arterial stiffness were not affected by the three diets at
fasting state. The markers were also measured at fasting and at 4 h
during mixed meal challenge, there was time trend effect
(P ¼ 0.000) where the index was decreased after all meals at 4 h
(Fig. 2, graphs G & H).Please cite this article in press as: Teng K-T, et al., Effects of exchanging carb
and thrombogenic responses in subjects with abdominal obesity: A ran
10.1016/j.clnu.2016.08.0264. Discussion
The present study was designed to investigate the effect of 7E%
replacement of SFA with reﬁned CARB or MUFA on cardiovascular-
related metabolic risk markers including inﬂammatory and
thrombogenic parameters, and the lipid proﬁle. The primary
outcome, fasting plasma IL-6 was not altered by 6 weeks exposure
to the three isocaloric diets: SFA (55% carbohydrate, 32% fat- 12%
SFA, 13% MUFA), CARB (61% carbohydrate, 25% fat- 5% SFA, 14%
MUFA) or MUFA (55% carbohydrate, 33% fat e 5% SFA, 20% MUFA).
Neither was there any substantial impact of dietarymodiﬁcation on
other cytokines (IL-1b and E-selectin), CRP, and thrombogenic
markers (PAI-1 and D-dimer), arterial stiffness (augmentation in-
dex) in the fasting state.
Epidemiological studies suggest that elevated fasting CRP and
IL-6 are associated with coronary heart disease [7,15]. The present
study subjects with central obesity had higher mean concentra-
tions of fasting cytokines, CRP and thrombogenic parameters at
baseline compared with normal weight, healthy Asian [16] and
Caucasian [17] individuals studied by other groups. The substitu-
tion of MUFA or reﬁned CARB for SFA however did not result in
improvement of these parameters in the fasting state in this groupohydrate ormonounsaturated fat with saturated fat on inﬂammatory
domized controlled trial, Clinical Nutrition (2016), http://dx.doi.org/
Fig. 2. Postprandial interleukin-6 (IL-6) (A), interleukin-1b (IL-1b) (B), C-reactive protein (CRP) (C), E-selectin (D), plasminogen activator inhibitor-1 (PAI-1) (E), D-dimer (F),
augmentation index (G), augmentation pressure (H) and triacylglycerol (I) following mixed meal rich in saturated fatty acid (SFA), carbohydrate (CARB) or monounsaturated fatty
acid (MUFA) at the end of each 3  6-week dietary intervention. Data are means (B and H) or geometric means (A, CeG and I) with 95% CI, n ¼ 46 (34 women, 12 men). White circle,
solid line ¼ SFA; white triangle, solid line ¼ CARB; white square, dotted line ¼MUFA. Repeated measures ANOVA of values from preprandial value (3 meals, 3 time points for A-F, 1
time point for G-H, 6 time points for I) with gender as a between subject factor: meal  time interaction: (AeC, EeH) P > 0.05, (D, I) P < 0.05; meal  time  gender interaction:
(AeI) P > 0.05. ϬSigniﬁcant differences in changes from preprandial value between CARB vs SFA and MUFA (I). Insert: Incremental areas under the curve (iAUC) over 6 h (AeF and I)
or 4 h (I). Data are geometric means with 95% CI. White bars ¼ SFA; black bars ¼ CARB; striped bars ¼ MUFA. *Signiﬁcant difference in iAUC between SFA and CARB or MUFA,
P < 0.05 (A, F and I).
K.-T. Teng et al. / Clinical Nutrition xxx (2016) 1e96of subjects who are vulnerable to disease progression. In agreement
with our ﬁndings, Lithander et al. [18] reported that fasting CRP, IL-
6 and TNF-a did not differ between a high SFA or low SFA fat diet
differing by 5E% fat after a 3-week crossover trial in mildly hyper-
lipidemic Caucasian subjects. A large scale study in a Caucasian
cohort of subjects at risk of developing metabolic syndrome also
found that altering the composition of SFA, MUFA coupled with
high or low glycemic index diet for a duration of six months did not
alter CRP, sICAMs, PAI-1 [19]. In contrast with the aforementionedPlease cite this article in press as: Teng K-T, et al., Effects of exchanging carb
and thrombogenic responses in subjects with abdominal obesity: A ran
10.1016/j.clnu.2016.08.026ﬁndings, a study in healthy subjects reported that an oleic acid
(MUFA) enriched diet reduced both CRP and IL-6 levels when
compared with trans fatty acids after a 4-week dietary intervention
[6]. Casas et al. [20] reported that Mediterranean diet supple-
mented with both nuts and extra virgin olive oil (a rich source of
MUFA) were found to lower plasma IL-6, CRP, sICAMs and P-selectin
compared with a low fat diet after a 1 y long term dietary inter-
vention in subjects at risk of developing cardiovascular diseases.
The study suggested that the nutrients in the Mediterranean dietohydrate ormonounsaturated fat with saturated fat on inﬂammatory
domized controlled trial, Clinical Nutrition (2016), http://dx.doi.org/
Fig. 2. (continued).
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impact of dietary modiﬁcation on inﬂammatory biomarkers related
to atherosclerosis. A study comparing the supplementation of n-3
PUFA (1100 mg), which is regarded as anti-inﬂammatory did not
improve subclinical inﬂammation, weight loss of 9.4 kg however
signiﬁcantly bring down the levels of cytokines [21,22]; this has
also been reviewed elsewhere [4].
A large scale long term study found that dietary fatty acids at
5E% exchange between SFA, reﬁned carbohydrates and MUFA did
not exert signiﬁcant impact on arterial stiffness and peripheral
augmentation index in subjects at high risk of developing meta-
bolic syndrome for a 6-mo intervention [23]. Observational
studies report higher sdHDL subfraction and lower large HDL
subfractions in the patient groups with the diagnosis of coronary
artery disease [24,25]. In addition, HDL3 may predict lower risk for
CHD [25]. The current study did not observe a change in % sdLDL
between diets, as reported by other similar studies [19]. The CARB
diet (in comparison with the SFA diet) however was associated
with lower fasting HDL cholesterol. Lipid subfraction analysis
showed that the decrease in HDL was due to a reduction in HDL3
which was associated with a concommitant increase in % sdHDL
when compared with SFA diet (P < 0.05). SFA diet on the other
hand increased the large HDL subfraction compared with both
CARB and MUFA diets (P < 0.05), respectively. A study comparing
soybean oil (MUFA) and butter (SFA) in hypercholesterolemic
Caucasians found no signiﬁcant difference in HDL-2 and HDL-3
subfractions after a 7-week diet intervention [26]. To our knowl-
edge, no similar studies compared the effects of high-fat and high-
carbohydrate in particular reﬁned carbohydrates diets on HDL
subfractions. Taken together, our study ﬁndings imply that high
carbohydrate consumption may increase CAD or CHD risk as
compared to high SFA intake as high reﬁned carbohydrate intake
is associated with higher sdHDL subfraction, lower large HDL
subfraction and lower HDL3.
The inﬂuence of dietary modiﬁcation on postprandial responses
is however different. The present study reveals that replacement of
SFA with reﬁned CARB in a mixed meal after a similar background
diet for 6 weeks elevated postprandial iAUC0e6 h of IL-6. On the
other hand, replacing SFAwithMUFA in a high fat snack elevated D-
dimer responses but not other parameters measured. PAI-1 and
augmentation index were found to decrease from baseline at 4 h
after all 3 meal challenges. In our previous published study on the
acute effect of mixed meal challenges with similar dietary compo-
sition conducted in metabolic syndrome Asian subjects, post-
prandial IL-1b, CRP and PAI-1 as in the present study were not
different between the 3 meals. However unlike our current study
(where postprandial IL-6 and D-dimer were higher after MUFA and
CARB meal-challenges respectively), in the acute setting without a
prior 6-week background diet exposure of similar composition to
themixedmeal, both IL-6/D-dimerwere not different between the 3
meal-challenges [27]. We expect to observe a more pronounced
effect of dietary fat modiﬁcation in overweight subjects as excess
central adipose tissue secretes proinﬂammatory markers and this
population is exposed to increased risk of developing chronic dis-
eases. However, in contrast to our expectations, our ﬁndings are in
concord with our previous study in healthy Asian subjects that 6
weeks exposure to diets high in SFA or MUFA do not differentially
affect IL-6, CRP, TNF-a and IL-1b levels after challenge meals [28]. It
has been reported that the ingestion of a minimum of 50 g fat is
needed for the detection of postprandial cytokine activation [29].
Previous studies consistently reported that high fat meals triggered
inﬂammatory responses (reviewed by our group [4]) and our study
indeed observed postprandial IL-6 elevationwith the use of 50 g fat
in the SAFA and MUFA challenges. The high reﬁned CARB meal
which only contained 20 g fat, increased postprandial IL-6 levels to aPlease cite this article in press as: Teng K-T, et al., Effects of exchanging carb
and thrombogenic responses in subjects with abdominal obesity: A ran
10.1016/j.clnu.2016.08.026greater extent when compared to the high-fat (SAFA) meal. This
coupled with the deleterious changes in HDL subfractions after the
high reﬁned CARB diet is of signiﬁcance in the light of controversy
about high reﬁned carbohydrate versus high fat diets. Our work
seems to indicate that even a short exposure to a high reﬁned CARB
diet leads to negative changes in surrogate inﬂammatory markers
and lipid component indicative of increased cardiovascular risk in
abdominally overweight Asian subjects. It has also been reported
that the optimal time to evaluate changes in CRP in blood plasma is
24h postprandially and this explains our observations of unchanged
CRP levels up to 6 h postprandially [30]. In studies using butter as a
dietary SFA source, butter was found to increase cytokines post-
prandially to a greater extent [31] compared with polyunsaturated
fats in obese subjects. One possible explanation might be that the
medium chain triglyceride content of butter is more rapidly absor-
bed compared with that of other SFA sources such as palm oil [32].
It is to be noted that no power calculations were carried out in
relation to the postprandial part of the study. There might be
chances of statistical type 1 errors due to the high number of sta-
tistical analyses performed. The consequencemight be that some of
the statistical differences are only observed by chance (for example
the group differences in iAUC for IL-6 and D-dimer). These results
need further conﬁrmation in a larger scale study with power
calculation. The strengths of our present dietary intervention study
are a standardized supervised well-controlled dietary intake by
study participants despite free-living conditions, good compliance
of study participants (as reﬂected by the post-intervention
cholesterol proﬁle as predicted by Mensink's equation [33] and
the erythrocytemembrane and plasma fatty acid composition), and
the long duration of assessment of the postprandial challenge (up
to 6 h). Another strength of our study is the higher proportion of
complex and reﬁned carbohydrate sources utilized which is
reﬂective of the dietary pattern in South East Asia and perhaps even
other Asian populations in India and China. In comparisonwith the
Mediterranean and typical American diets, effects of this
carbohydrate-heavy diet in Asian subjects which is consumed by a
large proportion of the world's population has not been as well
delineated in the literature. However our ﬁndings cannot therefore
be extrapolated to other populations with diets of differing
macronutrient composition. In addition, our ﬁndings in high
reﬁned carbohydrate diet cannot be related to diets high in com-
plex carbohydrates, which is the diet recommended by WHO.
The ﬁndings of the present study suggest that the replacement
of SFA with MUFA or reﬁned carbohydrates do not differentially
impact fasting inﬂammatory and thrombogenic markers in
abdominally overweight Asian individuals. High reﬁned carbohy-
drate consumption adversely impact on fasting HDL subfractions in
this high-risk group. Further conﬁrmation is needed on the impact
of high reﬁned carbohydrates and MUFA on proinﬂammatory and
thrombogenic responses postprandially.
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